Showing results (31-40 of 50) with videos related to
Sort By:
Pageof 5
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesicM D Swedberg, M J Sheardown, P Sauerberg, et al.The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.Schizophrenia Research|May 10, 2001
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidanceT Rasmussen, A Fink-Jensen, P Sauerberg, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232)F P Bymaster, D T Wong, C H Mitch, et al.European Journal of Pharmacology|October 17, 1998
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octaneF P Bymaster, H E Shannon, K Rasmussen, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1994
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptorsH E Shannon, F P Bymaster, D O Calligaro, et al.Pageof 5